Literature DB >> 31465107

Is Dual mTORC1 and mTORC2 Therapeutic Blockade Clinically Feasible in Cancer?

Nisha Unni1, Carlos L Arteaga1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31465107     DOI： 10.1001/jamaoncol.2019.2525

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  3 in total

1.  Discovery of potential mTOR inhibitors from Cichorium intybus to find new candidate drugs targeting the pathological protein related to the breast cancer: an integrated computational approach.

Authors:  Hezha O Rasul; Bakhtyar K Aziz; Dlzar D Ghafour; Arif Kivrak
Journal:  Mol Divers       Date:  2022-06-23       Impact factor: 2.943

2.  Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas.

Authors:  Shichuan Tan; Ryan Spear; Juan Zhao; Xiulian Sun; Pin Wang
Journal:  Front Genet       Date:  2022-06-27       Impact factor: 4.772

Review 3.  Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti-Breast Cancer Therapy.

Authors:  Yaseen Hussain; Haroon Khan; Waqas Alam; Michael Aschner; Khalaf F Alsharif; Luciano Saso
Journal:  Oxid Med Cell Longev       Date:  2022-06-27       Impact factor: 7.310
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.